Patent intelligence · US
US 11918578
Methods for treating cholestasis
Methods for treating cholestasis
Patent details — US 11918578
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 5, 2024
- Expiration
- Feb 29, 2044
- Applicant
- MIRUM PHARMACEUTICALS, INC.
- Claims
- 17
- CPC classes
- A61K, A61K31/4995, A61K31/554, A61K31/7042
Quick answer
US 11918578 (Methods for treating cholestasis) is held by MIRUM PHARMACEUTICALS, INC.. Status: granted. Granted Mar 5, 2024. Expires Feb 29, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- MIRUM PHARMACEUTICALS, INC.
- Grant date
- Expiration
- Claims
- 17
- CPC classes
- A61K, A61K31/4995, A61K31/554, A61K31/7042, A61K38/05, A61P
More from MIRUM PHARMACEUTICALS, INC.
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 11918578?
US 11918578 (Methods for treating cholestasis) is held by MIRUM PHARMACEUTICALS, INC.. Status: granted. Granted Mar 5, 2024. Expires Feb 29, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11918578?
MIRUM PHARMACEUTICALS, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 4 pharmaceutical patents for this assignee.
When does US 11918578 expire?
Our index shows an expiration date of Feb 29, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.